Concord Drugs Ltd.

Financial

	Concord Drugs	Shelter Pharma	Bacil Pharma
Operational Metrics
Financials
5 yr Average ROE	3.38 %	15.08 %	-73.86 %
5yr average Equity Multiplier	1.86	1.38	1.72
5yr Average Asset Turnover Ratio	0.9	2.02	0.0
5yr Avg Net Profit Margin	1.88 %	7.29 %	0.0
Price to Book	1.52	0.0	2.12
P/E	121.87	7.03	48.62
5yr Avg Cash Conversion Cycle	260.53 Days	151.86 Days	0.0
Inventory Days	138.17 Days	65.6 Days	0.0
Days Receivable	144.77 Days	77.72 Days	0.0
Days Payable	77.93 Days	5.04 Days	23.71 Days
5yr Average Interest Coverage Ratio	1.8	71.95	-950.16
5yr Avg ROCE	8.9 %	21.3 %	-81.01 %
5yr Avg Operating Profit Margin	9.09 %	11.0 %	0.0
5 yr average Debt to Equity	0.55	0.04	0.08
5yr CAGR Net Profit	-21.63 %	138.7 %	-28.45 %
5yr Average Return on Assets	1.77 %	11.22 %	-72.13 %
Shareholdings
Promoter Holding	54.39 %	52.32 %	0.2 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	5.39 %	-4.57 %	-42.47 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0